BMO Capital Markets Cuts Terns Pharmaceuticals (NASDAQ:TERN) Price Target to $15.00
Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its price objective cut by BMO Capital Markets from $26.00 to $15.00 in a report released on Tuesday morning,Benzinga reports. They currently have an outperform rating on the stock. A number of other brokerages have also recently weighed in on TERN. JMP Securities reiterated a “market outperform” rating […]
Terns Pharmaceuticals (NASDAQ:TERN – Free Report) had its price objective cut by BMO Capital Markets from $26.00 to $15.00 in a report released on Tuesday morning,Benzinga reports. They currently have an outperform rating on the stock. A number of other brokerages have also recently weighed in on TERN. JMP Securities reiterated a “market outperform” rating […]
